Published in Eukaryot Cell on August 01, 2003
The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74
Lessons from the genome sequence of Neurospora crassa: tracing the path from genomic blueprint to multicellular organism. Microbiol Mol Biol Rev (2004) 3.67
Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol (2006) 3.43
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun (2005) 3.13
The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97
A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell (2006) 1.88
Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell (2007) 1.76
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64
Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell (2007) 1.63
Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog (2011) 1.62
Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell (2005) 1.58
Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell (2004) 1.57
Cryptococcus gattii infections. Clin Microbiol Rev (2014) 1.55
Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan. J Clin Microbiol (2005) 1.50
Cryptococcus neoformans gene expression during experimental cryptococcal meningitis. Eukaryot Cell (2003) 1.49
The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun (2004) 1.48
HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog (2010) 1.47
Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans. Infect Immun (2009) 1.45
How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol (2009) 1.43
Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot Cell (2006) 1.41
Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell (2007) 1.36
Transcriptional regulation by protein kinase A in Cryptococcus neoformans. PLoS Pathog (2007) 1.32
A genetic linkage map of Cryptococcus neoformans variety neoformans serotype D (Filobasidiella neoformans). Genetics (2004) 1.32
Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun (2004) 1.31
Septins enforce morphogenetic events during sexual reproduction and contribute to virulence of Cryptococcus neoformans. Mol Microbiol (2009) 1.25
Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev (2004) 1.22
Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell (2006) 1.21
Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot Cell (2004) 1.19
Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol (2007) 1.17
UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis. Eukaryot Cell (2004) 1.16
Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J Biol Chem (2008) 1.14
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot Cell (2008) 1.13
CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun (2006) 1.12
Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryot Cell (2009) 1.08
Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet Biol (2009) 1.07
Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genet Biol (2009) 1.07
The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot Cell (2007) 1.05
Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii. MBio (2015) 0.99
Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot Cell (2010) 0.98
Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformans. Front Microbiol (2011) 0.98
Biosynthesis of UDP-GlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans. Biochem J (2004) 0.96
A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans. Eukaryot Cell (2009) 0.93
UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans. Eukaryot Cell (2008) 0.92
Yeasts in an industrial malting ecosystem. J Ind Microbiol Biotechnol (2006) 0.89
Sulphiredoxin plays peroxiredoxin-dependent and -independent roles via the HOG signalling pathway in Cryptococcus neoformans and contributes to fungal virulence. Mol Microbiol (2013) 0.88
Three galactose inducible promoters for use in C. neoformans var. grubii. Fungal Genet Biol (2008) 0.88
Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Eukaryot Cell (2007) 0.87
The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). Virulence (2012) 0.86
Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans. J Phys Chem B (2008) 0.85
Virulence-Associated Enzymes of Cryptococcus neoformans. Eukaryot Cell (2015) 0.84
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine (2011) 0.83
Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci. Infect Immun (2008) 0.83
Possible roles of ectophosphatases in host-parasite interactions. J Parasitol Res (2011) 0.81
A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One (2011) 0.81
The unfolded protein response (UPR) pathway in Cryptococcus. Virulence (2013) 0.81
Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity. MBio (2015) 0.81
Synthesis of cell envelope glycoproteins of Cryptococcus laurentii. Carbohydr Res (2007) 0.80
Virulence mechanisms and Cryptococcus neoformans pathogenesis. Fungal Genet Biol (2014) 0.80
Cryptococcus neoformans modulates extracellular killing by neutrophils. Front Microbiol (2011) 0.80
The vacuolar-sorting protein Snf7 is required for export of virulence determinants in members of the Cryptococcus neoformans complex. Sci Rep (2014) 0.79
Extracellular vesicles from Paracoccidioides pathogenic species transport polysaccharide and expose ligands for DC-SIGN receptors. Sci Rep (2015) 0.79
Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans. Eukaryot Cell (2009) 0.78
Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis. ACS Med Chem Lett (2015) 0.76
Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies. Infect Dis Rep (2014) 0.76
Identification and Functional Characterization of a Cryptococcus neoformans UPC2 Homolog. Mycobiology (2010) 0.76
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview. Front Immunol (2017) 0.75
Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans. Front Microbiol (2016) 0.75
Diagnostic Challenges of Cryptococcus neoformans in an Immunocompetent Individual Masquerading as Chronic Hydrocephalus. Case Rep Neurol Med (2016) 0.75
The presence of 3-hydroxy oxylipins in pathogenic microbes. Prostaglandins Other Lipid Mediat (2011) 0.75
Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii. Philos Trans R Soc Lond B Biol Sci (2016) 0.75
The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans. Sci Rep (2017) 0.75
New structural insights into Golgi Reassembly and Stacking Protein (GRASP) in solution. Sci Rep (2016) 0.75
Elucidation of the Role of 3-Hydroxy Fatty Acids in Cryptococcus-amoeba Interactions. Front Microbiol (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
G proteins and dual control of adenylate cyclase. Cell (1984) 11.05
A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia (1976) 6.24
cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem (1990) 5.02
Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med (1968) 4.97
Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev (1997) 4.28
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol (1996) 4.13
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Cryptococcus neoformans. 3. Inhibition of phagocytosis. J Bacteriol (1968) 3.48
Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun (1994) 3.46
Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc Natl Acad Sci U S A (1996) 3.35
Mating-type locus of Cryptococcus neoformans: a step in the evolution of sex chromosomes. Eukaryot Cell (2002) 3.12
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol (2001) 3.11
Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis (1984) 3.10
Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J Bacteriol (1967) 3.09
Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol (1982) 2.96
Distribution and deposition of inhaled particles in respiratory tract. Bacteriol Rev (1961) 2.95
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun (1977) 2.84
Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A (2002) 2.68
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol (1993) 2.50
The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J Immunol (1950) 2.47
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol (1994) 2.43
Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics (2001) 2.40
RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol (2000) 2.30
Molecular organization of the cell wall of Candida albicans. Med Mycol (2001) 2.28
Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol (2000) 2.24
Adenylyl cyclase functions downstream of the Galpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot Cell (2002) 2.21
What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis (1998) 2.18
Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect Immun (1996) 2.15
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun (1998) 2.12
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun (1988) 2.11
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol (1998) 2.10
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res (1990) 2.08
Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol Rev (2001) 2.04
Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis (1993) 2.03
Fungal cell wall synthesis: the construction of a biological structure. Microbiol Sci (1988) 2.02
Cell wall architecture in yeast: new structure and new challenges. J Bacteriol (1998) 1.87
How does Cryptococcus get its coat? Trends Microbiol (2000) 1.86
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun (1994) 1.83
Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc Natl Acad Sci U S A (2001) 1.80
The Cryptococcus neoformans STE12alpha gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating type specific. Mol Microbiol (1997) 1.79
Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol (1999) 1.79
Capsule synthesis by Cryptococcus neoformans. Trans N Y Acad Sci (1958) 1.76
The STE12alpha homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans. Genetics (1999) 1.75
Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol Microbiol (2001) 1.74
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res (1998) 1.72
Cell wall composition of the yeastlike and mycelial forms of Blastomyces dermatitidis. J Bacteriol (1971) 1.72
The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol (2002) 1.72
Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating. J Exp Med (2000) 1.71
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun (1995) 1.70
Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun (1998) 1.63
Intracellular fate of Cryptococcus neoformans. Infect Immun (1972) 1.63
Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun (1994) 1.57
Cell wall dynamics in yeast. Curr Opin Microbiol (1999) 1.57
Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol (2001) 1.57
Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J Immunol (2002) 1.56
Mating-type-specific and nonspecific PAK kinases play shared and divergent roles in Cryptococcus neoformans. Eukaryot Cell (2002) 1.55
Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol Immunol (1985) 1.54
Binding of cryptococcal polysaccharide to Cryptococcus neoformans. Infect Immun (1984) 1.52
Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol (1989) 1.52
Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans. EMBO Rep (2001) 1.46
Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol (2002) 1.45
Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc Natl Acad Sci U S A (2001) 1.44
Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan. Infect Immun (1988) 1.42
Cloning of a Cryptococcus neoformans gene, GPA1, encoding a G-protein alpha-subunit homolog. Infect Immun (1994) 1.39
RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics (2002) 1.38
Identification of a putative alpha-glucan synthase essential for cell wall construction and morphogenesis in fission yeast. Proc Natl Acad Sci U S A (1998) 1.36
Influence of cryptococcal antigens on cell-mediated immunity. Rev Infect Dis (1988) 1.33
Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans. J Med Vet Mycol (1990) 1.32
Paracoccidioides brasiliensis: cell wall structure and virulence. A review. Mycopathologia (1977) 1.32
Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect Immun (2001) 1.31
Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection. Infect Immun (2002) 1.31
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr Top Med Mycol (1985) 1.30
Mechanisms of bacterial pathogenicity. Postgrad Med J (2002) 1.29
Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol Microbiol (2001) 1.29
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun (1997) 1.28
Physical maps for genome analysis of serotype A and D strains of the fungal pathogen Cryptococcus neoformans. Genome Res (2002) 1.27
Microencapsulation of probiotic bacteria: technology and potential applications. Curr Issues Intest Microbiol (2002) 1.24
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants. Infect Immun (1986) 1.20
The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Proc Natl Acad Sci U S A (2001) 1.19
Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol Microbiol (2001) 1.15
Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J Clin Microbiol (1991) 1.14
Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infect Immun (2002) 1.12
UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J Bacteriol (1982) 1.12
Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms. Microbes Infect (1999) 1.10
The Cryptococcus neoformans genome sequencing project. Mycopathologia (1999) 1.10
Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun (2001) 1.08
Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans. Mycoses (1989) 1.06
Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin. J Biol Chem (2000) 1.03
A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59. Microbiology (2001) 1.02
Fine structural investigation of Malassezia furfur. II. The envelope of the yeast cells. Mycoses (1995) 1.01
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol (1990) 0.97
The yeast cell wall, a dynamic structure engaged in growth and morphogenesis. Biochem Soc Trans (1997) 0.96
Optimization of exopolysaccharide production by Tremella mesenterica NRRL Y-6158 through implementation of fed-batch fermentation. J Ind Microbiol Biotechnol (2002) 0.95
Rhinosporidiosis. Curr Top Med Mycol (1989) 0.94
Studies on capsule synthesis of Cryptococcus neoformans. Sabouraudia (1965) 0.94
Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice. Infect Immun (2002) 0.93
The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science (2005) 4.74
Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell (2004) 2.61
Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol (2003) 2.00
A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell (2006) 1.88
Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol (2007) 1.51
Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol (2002) 1.45
Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot Cell (2006) 1.41
Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol Microbiol (2007) 1.38
RNA interference in the pathogenic fungus Cryptococcus neoformans. Genetics (2002) 1.38
Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens. Eukaryot Cell (2005) 1.36
Gene silencing with RNA interference in the human pathogenic fungus Aspergillus fumigatus. FEMS Microbiol Lett (2004) 1.32
An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast (2004) 1.32
Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect Immun (2004) 1.31
Gene prediction and verification in a compact genome with numerous small introns. Genome Res (2004) 1.30
UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J Biol Chem (2004) 1.28
Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun (2003) 1.27
Toward an integrated model of capsule regulation in Cryptococcus neoformans. PLoS Pathog (2011) 1.21
Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot Cell (2004) 1.19
UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis. Eukaryot Cell (2004) 1.16
The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol Microbiol (2005) 1.14
Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans. J Biol Chem (2008) 1.14
An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J Biol Chem (2003) 1.14
Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J Biol Chem (2008) 1.14
The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Carbohydr Res (2009) 1.13
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot Cell (2008) 1.13
The SUN41 and SUN42 genes are essential for cell separation in Candida albicans. Mol Microbiol (2007) 1.12
Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot Cell (2007) 1.05
The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot Cell (2007) 1.05
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04
Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother (2006) 1.03
O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J Immunol (2004) 1.03
Glycosyltransferases and their products: cryptococcal variations on fungal themes. FEMS Yeast Res (2006) 1.00
The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans. Mol Biol Cell (2008) 0.98
Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods (2012) 0.98
Identification and functional demonstration of miRNAs in the fungus Cryptococcus neoformans. PLoS One (2012) 0.97
Silence of the strands: RNA interference in eukaryotic pathogens. Trends Microbiol (2003) 0.96
Biosynthesis of UDP-GlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans. Biochem J (2004) 0.96
Emerging themes in cryptococcal capsule synthesis. Curr Opin Struct Biol (2011) 0.96
Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation. J Biol Chem (2004) 0.95
Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast (2014) 0.94
The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium. FEMS Yeast Res (2006) 0.92
UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans. Eukaryot Cell (2008) 0.92
A beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases. J Biol Chem (2007) 0.91
Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans. J Biol Chem (2013) 0.89
A novel xylosylphosphotransferase activity discovered in Cryptococcus neoformans. J Biol Chem (2009) 0.88
Introns regulate gene expression in Cryptococcus neoformans in a Pab2p dependent pathway. PLoS Genet (2013) 0.87
Efficient implementation of RNA interference in the pathogenic yeast Cryptococcus neoformans. J Microbiol Methods (2011) 0.85
Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB. PLoS Pathog (2012) 0.85
Molecular phenotyping of mannosyltransferases-deficient Candida albicans cells by high-resolution magic angle spinning NMR. J Biochem (2009) 0.85
Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases. J Biol Chem (2012) 0.85
The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One (2013) 0.84
A xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis. J Biol Chem (2011) 0.84
Beta1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids. Eukaryot Cell (2008) 0.83
RNA interference in Cryptococcus neoformans. Methods Mol Biol (2012) 0.83
Members 5 and 6 of the Candida albicans BMT family encode enzymes acting specifically on β-mannosylation of the phospholipomannan cell-wall glycosphingolipid. Glycobiology (2012) 0.83
New regulators of biofilm development in Candida glabrata. Res Microbiol (2012) 0.81
A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One (2011) 0.81
An unusual organelle in Cryptococcus neoformans links luminal pH and capsule biosynthesis. Fungal Genet Biol (2009) 0.80
Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly. Eukaryot Cell (2014) 0.79
Identification of the galactosyltransferase of Cryptococcus neoformans involved in the biosynthesis of basidiomycete-type glycosylinositolphosphoceramide. Glycobiology (2013) 0.76
Biofilm formation studies in microtiter plate format. Methods Mol Biol (2012) 0.75